MedTrace Logo

Duragesic® (Fentanyl Transdermal System) Functionality Trial in Chronic Low Back Pain

NCT00237341 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 358

Last updated 2013-11-20

No results posted yet for this study

Summary

The purpose of this study is to assess physical functionality changes over a minimum of 9 weeks in patients with non-malignant chronic low back pain who are taking short-acting opioids (narcotic pain medications) for 4 or more weeks, and who start taking the long-acting opioid fentanyl in the form of a transdermal (skin) patch.

Conditions

  • Low Back Pain

Interventions

DRUG

fentanyl

Sponsors & Collaborators

  • PriCara, Unit of Ortho-McNeil, Inc.

    lead INDUSTRY

Principal Investigators

  • PriCara, Unit of Ortho-McNeil, Inc. Clinical Trial · PriCara, Unit of Ortho-McNeil, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-06-30
Completion
2004-01-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00237341 on ClinicalTrials.gov